Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 4
2017 2
2018 3
2019 4
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

14 results
Results by year
Filters applied: . Clear all
Page 1
Urachal cancer-current concepts of a rare cancer.
Reis H, Szarvas T. Reis H, et al. Pathologe. 2019 Jun;40(Suppl 1):31-39. doi: 10.1007/s00292-018-0516-9. Pathologe. 2019. PMID: 30895340 Review. English.
Urachal cancer is a rare but aggressive disease. In addition to the non-glandular tumors, non-cystic urachal adenocarcinomas are nowadays distinguished from the primary cystic variant. ...Finally, urachal adenocarcinomas seem to be a distinct entity on the mo
Urachal cancer is a rare but aggressive disease. In addition to the non-glandular tumors, non-cystic urachal adenocarcinomas a
[Urachal Cancer: an update of current molecular findings].
Reis H, Mairinger F, Ting S, Nagy N, Witzke KE, Kohl M, Sitek B, Niedworok C, Hadaschik B, Nyirády P, Szarvas T. Reis H, et al. Pathologe. 2019 Dec;40(Suppl 3):239-243. doi: 10.1007/s00292-019-00689-4. Pathologe. 2019. PMID: 31705235 German.
In the second project, the most relevant differential diagnostic markers between urachal adenocarcinomas and colorectal adenocarcinomas compared to normal tissue (urachal remnants) were determined by analyzing a miRNA panel. ...The sequence analyses data confirm the …
In the second project, the most relevant differential diagnostic markers between urachal adenocarcinomas and colorectal adenocarcinom …
Biomarkers in Urachal Cancer and Adenocarcinomas in the Bladder: A Comprehensive Review Supplemented by Own Data.
Reis H, Krafft U, Niedworok C, Módos O, Herold T, Behrendt M, Al-Ahmadie H, Hadaschik B, Nyirady P, Szarvas T. Reis H, et al. Dis Markers. 2018 Mar 12;2018:7308168. doi: 10.1155/2018/7308168. eCollection 2018. Dis Markers. 2018. PMID: 29721106 Free PMC article. Review.
Urachal cancer (UrC) is a rare but aggressive cancer. Due to overlapping histomorphology, discrimination of urachal from primary bladder adenocarcinomas (PBAC) and adenocarcinomas secondarily involving the bladder (particularly colorectal adenocarcinomas, CRC) can b
Urachal cancer (UrC) is a rare but aggressive cancer. Due to overlapping histomorphology, discrimination of urachal from prima
Pathogenic and targetable genetic alterations in 70 urachal adenocarcinomas.
Reis H, van der Vos KE, Niedworok C, Herold T, Módos O, Szendrői A, Hager T, Ingenwerth M, Vis DJ, Behrendt MA, de Jong J, van der Heijden MS, Peyronnet B, Mathieu R, Wiesweg M, Ablat J, Okon K, Tolkach Y, Keresztes D, Nagy N, Bremmer F, Gaisa NT, Chlosta P, Kriegsmann J, Kovalszky I, Timar J, Kristiansen G, Radzun HJ, Knüchel R, Schuler M, Black PC, Rübben H, Hadaschik BA, Schmid KW, van Rhijn BWG, Nyirády P, Szarvas T. Reis H, et al. Int J Cancer. 2018 Oct 1;143(7):1764-1773. doi: 10.1002/ijc.31547. Epub 2018 May 10. Int J Cancer. 2018. PMID: 29672836 Free article.
Urachal cancer (UrC) is a rare but aggressive malignancy often diagnosed in advanced stages requiring systemic treatment. Although cytotoxic chemotherapy is of limited effectiveness, prospective clinical studies can hardly be conducted. ...We therefore subjected 70 urac
Urachal cancer (UrC) is a rare but aggressive malignancy often diagnosed in advanced stages requiring systemic treatment. Although cy
Clinical, prognostic, and therapeutic aspects of urachal carcinoma-A comprehensive review with meta-analysis of 1,010 cases.
Szarvas T, Módos O, Niedworok C, Reis H, Szendröi A, Szász MA, Nyirády P. Szarvas T, et al. Urol Oncol. 2016 Sep;34(9):388-98. doi: 10.1016/j.urolonc.2016.04.012. Epub 2016 Jun 3. Urol Oncol. 2016. PMID: 27267737 Review.
BACKGROUND AND OBJECTIVES: Urachal carcinoma (UrC) is a rare and poorly investigated disease. Our current knowledge is mainly based on single-institutional studies. ...METHODS: A systematic Medline/PubMed search was performed on UrC using the terms "urachal carcinom …
BACKGROUND AND OBJECTIVES: Urachal carcinoma (UrC) is a rare and poorly investigated disease. Our current knowledge is mainly based o …
[Urachal cancer - current concepts of a rare cancer (German version)].
Reis H, Szarvas T. Reis H, et al. Pathologe. 2018 Dec;39(Suppl 2):291-300. doi: 10.1007/s00292-018-0498-7. Pathologe. 2018. PMID: 30470871 Review. German.
Urachal cancer is a rare but aggressive disease. In addition to the non-glandular tumors, non-cystic urachal adenocarcinomas are nowadays distinguished from the primary cystic variant. ...Finally, urachal adenocarcinomas seem to be a distinct entity on the mo
Urachal cancer is a rare but aggressive disease. In addition to the non-glandular tumors, non-cystic urachal adenocarcinomas a
Urachal Carcinoma of the Bladder: Impact of Clinical and Immunohistochemical Parameters on Prognosis.
Niedworok C, Panitz M, Szarvas T, Reis H, Reis AC, Szendröi A, Nyirády P, Szasz AM, Módos O, Rübben H, Vom Dorp F. Niedworok C, et al. J Urol. 2016 Jun;195(6):1690-6. doi: 10.1016/j.juro.2015.11.067. Epub 2015 Dec 8. J Urol. 2016. PMID: 26678957
PURPOSE: Urachal carcinoma of the bladder is a rare malignancy. Its histological phenotype is similar to that of primary bladder and colorectal adenocarcinoma. ...MATERIALS AND METHODS: Clinical and followup data were obtained on a total of 26 patients with urachal
PURPOSE: Urachal carcinoma of the bladder is a rare malignancy. Its histological phenotype is similar to that of primary bladder and …
Classic bladder exstrophy and adenocarcinoma of the bladder: Methylome analysis provide no evidence for underlying disease-mechanisms of this association.
Sharma A, Fröhlich H, Zhang R, Ebert AK, Rösch W, Reis H, Kristiansen G, Ellinger J, Reutter H. Sharma A, et al. Cancer Genet. 2019 Jun;235-236:18-20. doi: 10.1016/j.cancergen.2019.05.004. Epub 2019 May 31. Cancer Genet. 2019. PMID: 31296310 Clinical Trial.
In comparison to other bladder anomalies, CBE tissue methylation profiles differ from those of adenocarcinoma, adenocarcinoma with CBE, urothelial carcinoma and urachal carcinoma. ...
In comparison to other bladder anomalies, CBE tissue methylation profiles differ from those of adenocarcinoma, adenocarcinoma with CBE, urot …
14 results
Jump to page
Feedback